Nirmatrelvir and ritonavir treatment significantly reduces the risk of hospitalization and death from COVID-19 in high-risk individuals, according to a recent JAMA Network Open study. However, the treatment’s efficacy varied based on the degree of vulnerability, emphasizing tailored approaches for different risk groups.
AI advances could revolutionize hepatocellular carcinoma diagnosis
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. It is a major global health concern with rising rates, particularly in North Africa
December 29, 2023